Cargando…

Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation

BACKGROUND: In 2008, the Cochrane Collaboration introduced a tool for assessing the risk of bias in clinical trials included in Cochrane reviews. The risk of bias (RoB) tool is based on narrative descriptions of evidence-based methodological features known to increase the risk of bias in trials. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Savović, Jelena, Weeks, Laura, Sterne, Jonathan AC, Turner, Lucy, Altman, Douglas G, Moher, David, Higgins, Julian PT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022341/
https://www.ncbi.nlm.nih.gov/pubmed/24731537
http://dx.doi.org/10.1186/2046-4053-3-37
_version_ 1782316386348957696
author Savović, Jelena
Weeks, Laura
Sterne, Jonathan AC
Turner, Lucy
Altman, Douglas G
Moher, David
Higgins, Julian PT
author_facet Savović, Jelena
Weeks, Laura
Sterne, Jonathan AC
Turner, Lucy
Altman, Douglas G
Moher, David
Higgins, Julian PT
author_sort Savović, Jelena
collection PubMed
description BACKGROUND: In 2008, the Cochrane Collaboration introduced a tool for assessing the risk of bias in clinical trials included in Cochrane reviews. The risk of bias (RoB) tool is based on narrative descriptions of evidence-based methodological features known to increase the risk of bias in trials. METHODS: To assess the usability of this tool, we conducted an evaluation by means of focus groups, online surveys and a face-to-face meeting. We obtained feedback from a range of stakeholders within The Cochrane Collaboration regarding their experiences with, and perceptions of, the RoB tool and associated guidance materials. We then assessed this feedback in a face-to-face meeting of experts and stakeholders and made recommendations for improvements and further developments of the RoB tool. RESULTS: The survey attracted 380 responses. Respondents reported taking an average of between 10 and 60 minutes per study to complete their RoB assessments, which 83% deemed acceptable. Most respondents (87% of authors and 95% of editorial staff) thought RoB assessments were an improvement over past approaches to trial quality assessment. Most authors liked the standardized approach (81%) and the ability to provide quotes to support judgements (74%). A third of participants disliked the increased workload and found the wording describing RoB judgements confusing. The RoB domains reported to be the most difficult to assess were incomplete outcome data and selective reporting of outcomes. Authors expressed the need for more guidance on how to incorporate RoB assessments into meta-analyses and review conclusions. Based on this evaluation, recommendations were made for improvements to the RoB tool and the associated guidance. The implementation of these recommendations is currently underway. CONCLUSIONS: Overall, respondents identified positive experiences and perceptions of the RoB tool. Revisions of the tool and associated guidance made in response to this evaluation, and improved provision of training, may improve implementation.
format Online
Article
Text
id pubmed-4022341
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40223412014-05-16 Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation Savović, Jelena Weeks, Laura Sterne, Jonathan AC Turner, Lucy Altman, Douglas G Moher, David Higgins, Julian PT Syst Rev Research BACKGROUND: In 2008, the Cochrane Collaboration introduced a tool for assessing the risk of bias in clinical trials included in Cochrane reviews. The risk of bias (RoB) tool is based on narrative descriptions of evidence-based methodological features known to increase the risk of bias in trials. METHODS: To assess the usability of this tool, we conducted an evaluation by means of focus groups, online surveys and a face-to-face meeting. We obtained feedback from a range of stakeholders within The Cochrane Collaboration regarding their experiences with, and perceptions of, the RoB tool and associated guidance materials. We then assessed this feedback in a face-to-face meeting of experts and stakeholders and made recommendations for improvements and further developments of the RoB tool. RESULTS: The survey attracted 380 responses. Respondents reported taking an average of between 10 and 60 minutes per study to complete their RoB assessments, which 83% deemed acceptable. Most respondents (87% of authors and 95% of editorial staff) thought RoB assessments were an improvement over past approaches to trial quality assessment. Most authors liked the standardized approach (81%) and the ability to provide quotes to support judgements (74%). A third of participants disliked the increased workload and found the wording describing RoB judgements confusing. The RoB domains reported to be the most difficult to assess were incomplete outcome data and selective reporting of outcomes. Authors expressed the need for more guidance on how to incorporate RoB assessments into meta-analyses and review conclusions. Based on this evaluation, recommendations were made for improvements to the RoB tool and the associated guidance. The implementation of these recommendations is currently underway. CONCLUSIONS: Overall, respondents identified positive experiences and perceptions of the RoB tool. Revisions of the tool and associated guidance made in response to this evaluation, and improved provision of training, may improve implementation. BioMed Central 2014-04-15 /pmc/articles/PMC4022341/ /pubmed/24731537 http://dx.doi.org/10.1186/2046-4053-3-37 Text en Copyright © 2014 Savović et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Savović, Jelena
Weeks, Laura
Sterne, Jonathan AC
Turner, Lucy
Altman, Douglas G
Moher, David
Higgins, Julian PT
Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
title Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
title_full Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
title_fullStr Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
title_full_unstemmed Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
title_short Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
title_sort evaluation of the cochrane collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022341/
https://www.ncbi.nlm.nih.gov/pubmed/24731537
http://dx.doi.org/10.1186/2046-4053-3-37
work_keys_str_mv AT savovicjelena evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation
AT weekslaura evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation
AT sternejonathanac evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation
AT turnerlucy evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation
AT altmandouglasg evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation
AT moherdavid evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation
AT higginsjulianpt evaluationofthecochranecollaborationstoolforassessingtheriskofbiasinrandomizedtrialsfocusgroupsonlinesurveyproposedrecommendationsandtheirimplementation